XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $451,000 | +162.2% | 99,860 | +185.1% | 0.00% | – |
| Q4 2020 | $172,000 | +12.4% | 35,031 | +35.9% | 0.00% | – |
| Q3 2020 | $153,000 | +188.7% | 25,772 | +29.4% | 0.00% | – |
| Q2 2020 | $53,000 | +96.3% | 19,915 | +46.3% | 0.00% | – |
| Q1 2020 | $27,000 | -59.7% | 13,617 | +40.7% | 0.00% | – |
| Q4 2019 | $67,000 | -8.2% | 9,675 | +28.3% | 0.00% | – |
| Q3 2019 | $73,000 | -68.1% | 7,539 | -62.7% | 0.00% | – |
| Q2 2019 | $229,000 | -33.8% | 20,221 | -41.5% | 0.00% | – |
| Q1 2019 | $346,000 | +208.9% | 34,578 | +415.8% | 0.00% | – |
| Q4 2018 | $112,000 | -77.4% | 6,704 | -76.3% | 0.00% | – |
| Q3 2018 | $495,000 | – | 28,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |